21197148|t|Pharmacotherapies for obesity: past, current, and future therapies.
21197148|a|Past therapies for the treatment of obesity have typically involved pharmacological agents usually in combination with a calorie-controlled diet. This paper reviews the efficacy and safety of pharmacotherapies for obesity focusing on drugs approved for long-term therapy (orlistat), drugs approved for short-term use (amfepramone [diethylpropion], phentermine), recently withdrawn therapies (rimonabant, sibutamine) and drugs evaluated in Phase III studies (taranabant, pramlintide, lorcaserin and tesofensine and combination therapies of topiramate plus phentermine, bupropion plus naltrexone, and bupropion plus zonisamide). No current pharmacotherapy possesses the efficacy needed to produce substantial weight loss in morbidly obese patients. Meta-analyses support a significant though modest loss in bodyweight with a mean weight difference of 4.7 kg (95% CI 4.1 to 5.3 kg) for rimonabant, 4.2 kg (95% CI 3.6 to 4.8 kg) for sibutramine and 2.9 kg (95% CI 2.5 to 3.2 kg) for orlistat compared to placebo at >=12 months. Of the Phase III pharmacotherapies, lorcaserin, taranabant, topiramate and bupropion with naltrexone have demonstrated significant weight loss compared to placebo at >=12 months. Some pharmacotherapies have also demonstrated clinical benefits. Further studies are required in some populations such as younger and older people whilst the long term safety continues to be a major consideration and has led to the withdrawal of several drugs.
21197148	22	29	obesity	Disease	MESH:D009765
21197148	104	111	obesity	Disease	MESH:D009765
21197148	282	289	obesity	Disease	MESH:D009765
21197148	340	348	orlistat	Chemical	MESH:D000077403
21197148	386	397	amfepramone	Chemical	MESH:D004053
21197148	399	413	diethylpropion	Chemical	MESH:D004053
21197148	416	427	phentermine	Chemical	MESH:D010645
21197148	460	470	rimonabant	Chemical	MESH:D000077285
21197148	472	482	sibutamine	Chemical	-
21197148	526	536	taranabant	Chemical	MESH:C521311
21197148	551	561	lorcaserin	Chemical	MESH:C506658
21197148	566	577	tesofensine	Chemical	MESH:C518479
21197148	607	617	topiramate	Chemical	MESH:D000077236
21197148	623	634	phentermine	Chemical	MESH:D010645
21197148	636	645	bupropion	Chemical	MESH:D016642
21197148	651	661	naltrexone	Chemical	MESH:D009271
21197148	667	676	bupropion	Chemical	MESH:D016642
21197148	682	692	zonisamide	Chemical	MESH:D000078305
21197148	775	786	weight loss	Disease	MESH:D015431
21197148	799	804	obese	Disease	MESH:D009765
21197148	805	813	patients	Species	9606
21197148	865	883	loss in bodyweight	Disease	MESH:D015431
21197148	951	961	rimonabant	Chemical	MESH:D000077285
21197148	997	1008	sibutramine	Chemical	MESH:C058254
21197148	1047	1055	orlistat	Chemical	MESH:D000077403
21197148	1128	1138	lorcaserin	Chemical	MESH:C506658
21197148	1140	1150	taranabant	Chemical	MESH:C521311
21197148	1152	1162	topiramate	Chemical	MESH:D000077236
21197148	1167	1176	bupropion	Chemical	MESH:D016642
21197148	1182	1192	naltrexone	Chemical	MESH:D009271
21197148	1223	1234	weight loss	Disease	MESH:D015431
21197148	Cotreatment	MESH:D009271	MESH:D016642
21197148	Cotreatment	MESH:D000077236	MESH:D010645
21197148	Negative_Correlation	MESH:C506658	MESH:D009765
21197148	Negative_Correlation	MESH:C521311	MESH:D015431
21197148	Negative_Correlation	MESH:C058254	MESH:D009765
21197148	Negative_Correlation	MESH:D004053	MESH:D009765
21197148	Negative_Correlation	MESH:D000077285	MESH:D009765
21197148	Cotreatment	MESH:D000078305	MESH:D016642
21197148	Negative_Correlation	MESH:D000078305	MESH:D009765
21197148	Negative_Correlation	MESH:D009271	MESH:D015431
21197148	Negative_Correlation	MESH:D016642	MESH:D015431
21197148	Negative_Correlation	MESH:D000077285	MESH:D015431
21197148	Negative_Correlation	MESH:D016642	MESH:D009765
21197148	Negative_Correlation	MESH:D000077236	MESH:D015431
21197148	Negative_Correlation	MESH:D000077403	MESH:D009765
21197148	Negative_Correlation	MESH:C058254	MESH:D015431
21197148	Positive_Correlation	MESH:D000077403	MESH:D015431
21197148	Negative_Correlation	MESH:C506658	MESH:D015431
21197148	Negative_Correlation	MESH:D010645	MESH:D009765
21197148	Negative_Correlation	MESH:D009271	MESH:D009765
21197148	Negative_Correlation	MESH:D000077236	MESH:D009765
21197148	Negative_Correlation	MESH:C521311	MESH:D009765

